MIDODRINE HYDROCHLORIDE (midodrine hydrochloride) by Rubicon Biotechnology is clinical pharmacology mechanism of action: midodrine hydrochloride forms an active metabolite, desglymidodrine, that is an alpha 1 -agonist, and exerts its actions via activation of the alpha-adrenergic receptors of the arteriolar and venous 1 vasculature, producing an increase in vascular tone and elevation of blood pressure. Approved for symptomatic orthostatic hypotension (oh). First approved in 2019.
Drug data last refreshed 18h ago
CLINICAL PHARMACOLOGY Mechanism of Action: Midodrine hydrochloride forms an active metabolite, desglymidodrine, that is an alpha 1 -agonist, and exerts its actions via activation of the alpha-adrenergic receptors of the arteriolar and venous 1 vasculature, producing an increase in vascular tone and…
Worked on MIDODRINE HYDROCHLORIDE at Rubicon Biotechnology? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.